c

e-learning | Ertugliflozin in type 2 diabetes and the other SGLT-2 inhibitors

20th September 2019 by Louise Hudman

e-learning | Ertugliflozin in type 2 diabetes and the other SGLT-2 inhibitors

This is a new guideline from NICE giving advice on ertugliflozin, published in April 2019. I am also doing a quick reminder about the other SGLT-2 inhibitors.

What is ertugliflozin?

It is another sodium-glucose co-transporter 2 (SGLT-2) inhibitor, like canagliflozin, dapagliflozin and empagliflozin.

It is thought to be as effective as the other SGLT-2 inhibitors, but it is cheaper.

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

Related content

"We have used LocumDeck for a number of months now and find it really useful when booking locums. You can see the availability of GPs, their documents are all loaded on the site and you can book instantly – it takes minutes to do. There are also no expensive locum agency fees to pay – just the GP’s actual payment. It's quick and hassle-free."

Lesley Munro-Faure, Managing Partner, Unity Health, Buckinghamshire

See the full list of features within our NASGP membership plans

Membership